Source: Nutraceutical Business Review

Symrise: Symrise delivers solid growth in Q1 and reaffirms outlook

Symrise AG had a healthy start into the 2025 fiscal year, with organic growth of 4.2% in the first quarter. Reported sales rose 2.0% to €1,317 million (Q1 2024: €1,292 million) supported by the strength of the Group's diversified, innovation-led portfolio as well as higher volumes across both segments and sustained customer demand

Read full article »
Annual Revenue
$5.0-10B
Employees
10-50K
Jean-Yves Parisot's photo - CEO of Symrise

CEO

Jean-Yves Parisot

CEO Approval Rating

75/100

Read more